RHUMBLINE ADVISERS - CULLINAN ONCOLOGY INC ownership

CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 100 filers reported holding CULLINAN ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of CULLINAN ONCOLOGY INC
ValueSharesWeighting
Q3 2023$409,402
-17.7%
45,239
-2.1%
0.00%
-100.0%
Q2 2023$497,402
+95005.5%
46,227
-9.5%
0.00%0.0%
Q1 2023$523
+6.1%
51,093
+9.4%
0.00%0.0%
Q4 2022$493
-99.9%
46,693
+2.0%
0.00%0.0%
Q3 2022$587,000
+6.1%
45,782
+6.2%
0.00%0.0%
Q2 2022$553,000
+64.6%
43,123
+34.6%
0.00%
Q1 2022$336,000
-28.8%
32,045
+4.7%
0.00%
-100.0%
Q4 2021$472,000
-32.6%
30,600
-1.4%
0.00%0.0%
Q3 2021$700,000
+80.9%
31,025
+106.5%
0.00%0.0%
Q2 2021$387,000
-19.9%
15,027
+29.7%
0.00%0.0%
Q1 2021$483,00011,5840.00%
Other shareholders
CULLINAN ONCOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
MPM BioImpact LLC 7,648,268$98,051,00027.24%
CHI Advisors LLC 3,047,609$39,070,00014.92%
Nextech Invest Ltd. 1,221,145$15,655,0005.28%
BVF INC/IL 7,509,059$96,266,0004.65%
TANG CAPITAL MANAGEMENT LLC 609,231$7,810,0001.18%
Boxer Capital, LLC 1,074,082$13,770,0000.87%
SILVERARC CAPITAL MANAGEMENT, LLC 213,090$2,732,0000.84%
Atom Investors LP 96,880$1,242,0000.54%
EcoR1 Capital, LLC 1,169,889$14,998,0000.52%
Birchview Capital, LP 45,114$578,0000.42%
View complete list of CULLINAN ONCOLOGY INC shareholders